HCONRES 42
117th Congress
House
Health
Civil actions and liability
Consumer affairs
Drug trafficking and controlled substances
Prescription drugs
Solid waste and recycling
State and local finance
State and local government operations
Transportation costs
Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
Introduced: July 21, 2021
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 22, 2021
Referred to the Subcommittee on Health.
Jul 21, 2021
Referred to the House Committee on Energy and Commerce.
Jul 21, 2021
Introduced in House
Plain-English summary
This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2